Sort by
Refine Your Search
-
, and scholarly activities. PharmD Fellowship Program – Global Scientific Communications Location: Scholar Rock, Cambridge, MA (Hybrid) Duration: 2 Years Scholar Rock is a biopharmaceutical company that
-
Details Posted: Unknown Location: Salary: Summary: Summary here. Details Posted: 07-Jan-26 Location: Boston, Massachusetts Type: Full-time Categories: Academic/Faculty Communications/Journalism
-
, and scholarly activities. In partnership with Northeastern University, Pacira BioSciences is offering a two-year Global Medical Information and Communications fellowship, based in New Jersey. About
-
, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Global Patient Safety and Risk Management fellowship, based in Cambridge, MA. About
-
that safeguard both clinical and non-clinical networks. This work will directly impact patient safety and digital resilience in some of the most vulnerable healthcare settings. Success in this role will help
-
About the Opportunity About Khoury College Khoury College is committed to building a community of belonging among students, faculty and staff. We strongly encourage applicants from individuals with
-
Biologics, Fosun Pharma, Genentech, a member of the Roche Group, Genevant, Genmab, MediLink, OncoC4, Pfizer and Regeneron. At BioNTech, we are more than just a biotechnology company – we are a community of
-
opportunity to work collaboratively with other functional areas within Ironwood, including global patient safety, clinical development, medical scientific affairs, program management, data sciences, quality and
-
algorithms. The candidate should have the following skills: • Strong technical, analytical, and quantitative abilities; • Strong interpersonal, organizational, and communication skills, and the willingness
-
to the development of clinical sections of regulatory documents such as Investigators' Brochures, briefing books, safety updates, IND/NDA submission documents, and responses to Health Authorities questions Engagement